During the height of the COVID-19 pandemic, Alltech Engineering Corp millwrights helped transform the facility featured in this 60 Minutes story.
Ginkgo Bioworks is working on optimizing the manufacturing process for RNA – the key ingredient in vaccines produced by Pfizer/BioNtech and Moderna. RNA instructs cells to produce proteins that trigger the body to fight the coronavirus. https://t.co/w7tcvlUjpz pic.twitter.com/ZKpIY8Bwb8
— 60 Minutes (@60Minutes) March 1, 2021